Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02486237
NCT02486237CompletedNot Applicable

Complications in Central American Diabetic Patients: Historic Cohort

Clínica Los Yoses8 sites in 4 countries225 target enrollmentStarted: September 2015Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
225
Locations
8
Primary Endpoint
Number of patients with microvascular and cardiovascular complications
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Retrospective, observational study to determine the prevalence of complications in Central American diabetic patients.

Detailed Description

This is retrospective observational study aimed to determine the prevalence of complications in Central American diabetic patients. Patients included are treated in the usual outpatient practice setting and we will try to determine the prevalence of diabetic complications in these patients.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •type 2 diabetes mellitus diagnosed between 2004 and 2009
  • •seen by the attending physician for the first time between January and December
  • •male or female patients between 18 and 80 years

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of patients with microvascular and cardiovascular complications

Time Frame: up to 10 years

Secondary Outcomes

  • Number of participants with at least one episode of hypoglycemia(up to 10 years)
  • Number of patients with microvascular and cardiovascular complications stratified by their glucose control(up to 10 years)
  • Number of patients with microvascular and cardiovascular complications stratified by blood pressure control(up to 10 years)
  • Number of patients with microvascular and cardiovascular complications stratified by diabetes pharmacologic treatment(up to 10 years)
  • Number of patients with microvascular and cardiovascular complications stratified by cholesterol levels(up to 10 years)

Investigators

Sponsor
Clínica Los Yoses
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chih Hao Chen Ku

MD

Clínica Los Yoses

Study Sites (8)

Loading locations...

Similar Trials

Completed
Not Applicable
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian PopulationDiabetes Mellitus, Type 1OnychauxisDiabetes Mellitus, Type 2OnychomycosisFoot DeformitiesFoot Ulcer, DiabeticNeuropathy, DiabeticHyperkeratosis
NCT04327622LMC Diabetes & Endocrinology Ltd.5,084
Active, not recruiting
Not Applicable
Poznan Prospective Study of Type 1 Diabetic PatientsInsulin Treatment OvercorrectionMacroangiopathyMicroangiopathyInsulin Resistance
NCT01411033Poznan University of Medical Sciences100
Terminated
Not Applicable
Time To Complications Occurs in DiabetesNephropathyDiabetic NeuropathyIschemic Heart DiseaseRetinopathyVascular Disease
NCT00969956Karolinska Institutet17
Completed
Not Applicable
Diabetic Patients With End-Stage Renal DiseaseEnd-Stage Renal DiseaseCardiovascular DiseasesDiabetes
NCT00435786Rigshospitalet, Denmark
Completed
Not Applicable
Characterization of the Charcot FootCharcot's JointComplications of Diabetes Mellitus
NCT02335931Bispebjerg Hospital21